Federal Register / Vol. 74, No. 131 / Friday, July 10, 2009 / Notices 33265 

disabilities programs, only the PADD 

program requires an SGP. Following the 

required public input for the coming 

fiscal year, the P&As submit the final 

version of this SGP to the 

Administration on Developmental 

Disabilities (ADD). ADD will aggregate 

the information in the SGPs into a 

national profile of programmatic 

emphasis for P&A Systems in the 

coming year. This aggregation will 

provide ADD with a tool for monitoring 

of the public input requirement. 

Furthermore, it will provide an 

overview of program direction, and 

permit ADD to track accomplishments 

against goals/targets, permitting the 

formulation of technical assistance and 

compliance with the Government 

Performance and Results Act of 1993. 

Respondents: State and Tribal 

Governments. 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average burden 

hours per 

response 

Total burden 

hours 

P&A SGP ................................................................................................. 57 1 44 2,508 

Estimated Total Annual Burden 

Hours: 2,508. 

Additional Information 

Copies of the proposed collection may 

be obtained by writing to the 

Administration for Children and 

Families, Office of Administration, 

Office of Information Services, 370 

L’Enfant Promenade, SW., Washington, 

DC 20447, Attn: ACF Reports Clearance 

Officer. All requests should be 

identified by the title of the information 

collection. E-mail address: 

infocollection@acf.hhs.gov. 

OMB Comment 

OMB is required to make a decision 

concerning the collection of information 

between 30 and 60 days after 

publication of this document in the 

Federal Register. Therefore, a comment 

is best assured of having its full effect 

if OMB receives it within 30 days of 

publication. Written comments and 

recommendations for the proposed 

information collection should be sent 

directly to the following: Office of 

Management and Budget, Paperwork 

Reduction Project; Fax: 202–395–7245, 

Attn: Desk Officer for the 

Administration for Children and 

Families. 

Dated: July 7, 2009. 

Janean Chambers, 

Reports Clearance Officer. 

[FR Doc. E9–16317 Filed 7–9–09; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel, NIH Pathway to Independence 

Awards. 

Date: July 27–28, 2009. 

Time: 7 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Double Tree Hotel Bethesda, 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Meredith D. TempleO’Connor, PhD, Scientific Review Officer, 

Office of Scientific Review, National Institute 

of General Medical Sciences, National 

Institutes of Health, 45 Center Drive, Room 

3AN12C, Bethesda, MD 20892, 301–594– 

2772, templeocm@mail.nih.gov. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel, Faculty Recruitment—ARRA Funds. 

Date: July 28–29, 2009. 

Time: 6 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Double Tree Hotel Bethesda, 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Rebecca H. Johnson, PhD, 

Scientific Review Officer, Office of Scientific 

Review, National Institute of General Medical 

Sciences, National Institutes of Health, 

Natcher Building, Room 3AN18, Bethesda, 

MD 20892, 301–594–2771, 

johnsonrh@nigms.nih.gov. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel, Faculty Recruitment— ARRA Funds. 

Date: July 28–29, 2009. 

Time: 6 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Double Tree Hotel Bethesda, 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Meredith D. TempleO’Connor, PhD, Scientific Review Officer, 

Office of Scientific Review, National Institute 

of General Medical Sciences, National 

Institutes of Health, 45 Center Drive, Room 

3AN12C, Bethesda, MD 20892, 301–594– 

2772, templeocm@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives; 93.701, ARRA 

Related Biomedical Research and Research 

Support Awards, National Institutes of 

Health, HHS) 

Dated: July 1, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–16068 Filed 7–9–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2009–N–0295] 

Providing Effective Information to 

Consumers About Prescription Drug 

Risks and Benefits; Public Workshop 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of public workshop; 

request for comments. 

SUMMARY: The Food and Drug 

Administration (FDA) Center for Drug 

Evaluation and Research (CDER), in 

collaboration with FDA’s Office of the 

Commissioner (OC), is announcing a 

public workshop entitled ‘‘Providing 

Effective Information to Consumers 

About Prescription Drug Risks and 

Benefits.’’ This public workshop is 

intended to explore potential 

approaches that will result in written 


sroberts on DSKD5P82C1PROD with NOTICES